AstraZeneca potassium drug finally approved, threatening Vifor

LONDON (Reuters) - The decision by U.S. regulators to finally approve AstraZeneca's much-delayed excess potassium drug Lokelma gives the group another new medicine launch, boosting its portfolio as it…
Read the full story: Reuters: Health News